Hyperbaric Oxygen Therapy as Adjunctive Treatment of Chronic Diabetic Foot Ulcers

NCT ID: NCT00953186

Last Updated: 2011-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-06-30

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate if hyperbaric oxygen therapy heels more foot ulcers as compared to placebo in patients with diabetes mellitus and chronic foot ulcers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Foot Ulcer Healing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HBOT

100 % oxygen at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks

Group Type ACTIVE_COMPARATOR

HBOT

Intervention Type DEVICE

100 % oxygen at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks treatment given in hyperbaric chamber

Placebo

air at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks

Group Type PLACEBO_COMPARATOR

hyperbaric air

Intervention Type DEVICE

air at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks treatment given in hyperbaric chamber

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hyperbaric air

air at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks treatment given in hyperbaric chamber

Intervention Type DEVICE

HBOT

100 % oxygen at 2,5 atmospheres for 90 minutes/day, 5 days a week for 8 weeks treatment given in hyperbaric chamber

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diabetes mellitus,
* foot ulcer with duration \> 3 months,
* treatment at Diabetes foot clinic for \> 2 months,
* vascular surgical intervention had not been recommended for the affected lower limb.

Exclusion Criteria

* severe obstructive pulmonary disease,
* malignancy and untreated thyrotoxicosis),
* current drug or alcohol misuse,
* vascular surgery in the lower limbs within the last two months,
* participation in another study or suspected poor compliance.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lund University

OTHER

Sponsor Role collaborator

Region Skåne Sweden

OTHER_GOV

Sponsor Role collaborator

Gorthons Foundation Helsingborg Sweden

UNKNOWN

Sponsor Role collaborator

Mrs. Thelma Zoegas Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dept Endocrinology, Lund University Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Magnus Löndahl, MD

Role: PRINCIPAL_INVESTIGATOR

Inst Clinical Sciences in Lund, Lund University, Sweden

Per L Katzman, ass prof, MD

Role: STUDY_CHAIR

Inst Clinical Sciences in Lund, Lund University, Sweden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept Anesthesiology, Helsingborg Hospital

Helsingborg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Londahl M, Katzman P, Nilsson A, Hammarlund C, Sellman A, Wykman A, Hugo-Persson M, Apelqvist J. A prospective study: hyperbaric oxygen therapy in diabetics with chronic foot ulcers. J Wound Care. 2006 Nov;15(10):457-9. doi: 10.12968/jowc.2006.15.10.26970.

Reference Type BACKGROUND
PMID: 17124820 (View on PubMed)

Londahl M, Katzman P, Hammarlund C, Nilsson A, Landin-Olsson M. Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia. 2011 Jan;54(1):65-8. doi: 10.1007/s00125-010-1946-y. Epub 2010 Oct 19.

Reference Type DERIVED
PMID: 20957342 (View on PubMed)

Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010 May;33(5):998-1003. doi: 10.2337/dc09-1754.

Reference Type DERIVED
PMID: 20427683 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Z012094

Identifier Type: -

Identifier Source: org_study_id